Imaflex Inc
SymbolIFX.A
Shares Issued39,350,002
Close 2009-07-31C$ 0.30
Recent Sedar Documents

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

Imaflex earns $79,000 in Q2

2009-08-12 23:36 ET - News Release

Mr. Joseph Abbandonato reports

IMAFLEX INC. ANNOUNCES RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2009

Imaflex Inc. is releasing its results for the second quarter ended June 30, 2009. 

                              HIGHLIGHTS
 (in thousands of dollars, except per-share amounts and as indicated)

                                    Second    Second  Year to   Year to
                                   quarter   quarter  date in   date in
                                   of 2009   of 2008     2009      2008

Sales                               12,384    14,014    26,195    26,128
Cost of sales                       10,229    12,100    21,300    22,337
Gross profit (before
amortization)                        2,155     1,914     4,895     3,791
Gross profit (%) (before
amortization)                         17.4%     13.7%     18.7%     14.5%
Amortization of production
equipment                              715       778     1,450     1,505
Gross profit                         1,440     1,136     3,445     2,286
Gross profit (%)                      11.6%      8.1%     13.2%      8.7%
Expenses                               892     1,310     2,022     2,648
FX loss (gain)                         260        37       247       137
Income (loss) before income taxes      288      (211)    1,176      (499)
Provision for income taxes             209        70       453       258
Net income (loss)                       79      (281)      723      (757)
Basic and diluted earnings per
share                              $ 0.002   $(0.010)  $ 0.018   $(0.020)
EBITDA                               1,162       777     2,995     1,599

EBITDA means earnings before interest, taxes, depreciation and 
amortization.

The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.